{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:36:45Z","timestamp":1791193005254,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.3892\/ijo.2012.1572","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T09:59:49Z","timestamp":1343210389000},"page":"1213-1220","source":"Crossref","is-referenced-by-count":54,"title":["First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)"],"prefix":"10.3892","volume":"41","author":[{"given":"K.","family":"EICHLER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"ZANGOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"MACK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"HAMMERSTINGL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"GRUBER-ROUH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"GALLUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"VOGL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"key20180110114404_b1-ijo-41-04-1213","article-title":"Trans-arterial chemoembolisation of metastatic colorectal carcinoma (mCRC) to the liver adopting polyvinylalcohol microspheres loaded with irinotecan (DEBIRI) compared to FOLFIRI (CT): evaluation at two years of a phase III clinical trial","volume":"21","author":"Fiorentini","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180110114404_b2-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180110114404_b3-ijo-41-04-1213","article-title":"Cancer management: a multidisciplinary approach","volume-title":"Medical, Surgical and Radiation Oncology","author":"Pazdur","year":"2004","edition":"7th edition"},{"key":"key20180110114404_b4-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","article-title":"Liver resection for colorectal metastases","volume":"15","author":"Fong","year":"1997","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"key20180110114404_b5-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/annonc\/mdg731","article-title":"Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases","volume":"14","author":"Adam","year":"2003","journal-title":"Ann Oncol"},{"key":"key20180110114404_b6-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"key20180110114404_b7-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)92529-1","article-title":"Factors influencing the natural history of colorectal liver metastases","volume":"343","author":"Stangl","year":"1994","journal-title":"Lancet"},{"key":"key20180110114404_b8-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00316981","article-title":"Resection of colorectal liver metastases","volume":"19","author":"Scheele","year":"1995","journal-title":"World J Surg"},{"key":"key20180110114404_b9-ijo-41-04-1213","first-page":"351","article-title":"Hepatic colorectal metastasis: current surgical therapy, selection criteria for hepatectomy, and role for adjuvant therapy","volume":"34","author":"Fong","year":"2000","journal-title":"Adv Surg"},{"key":"key20180110114404_b10-ijo-41-04-1213","first-page":"1489","article-title":"Hepatic colorectal metastasis: current status of surgical therapy","volume":"12","author":"Fong","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"key20180110114404_b11-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180110114404_b12-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","article-title":"Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium","volume":"68","author":"Kennedy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180110114404_b13-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00104-005-1047-5","article-title":"Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment","volume":"76","author":"Germer","year":"2005","journal-title":"Chirurg"},{"key":"key20180110114404_b14-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.RVI.0000196277.76812.A3","article-title":"Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies","volume":"17","author":"Brown","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"key20180110114404_b15-ijo-41-04-1213","first-page":"95","article-title":"Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104)","volume":"5","author":"Bavisotto","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180110114404_b16-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1148\/radiol.2302020646","article-title":"Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data","volume":"230","author":"Vogl","year":"2004","journal-title":"Radiology"},{"key":"key20180110114404_b17-ijo-41-04-1213","first-page":"1085","article-title":"Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study","volume":"21","author":"Fiorentini","year":"2007","journal-title":"In Vivo"},{"key":"key20180110114404_b18-ijo-41-04-1213","first-page":"3793","article-title":"Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results","volume":"26","author":"Aliberti","year":"2006","journal-title":"Anticancer Res"},{"key":"key20180110114404_b19-ijo-41-04-1213","article-title":"A preclinical study to evaluate the plasma levels of irinotecan after hepatic embolisation using drug loaded in a porcine model","author":"Rofe","year":"2006"},{"key":"key20180110114404_b20-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key20180110114404_b21-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180110114404_b22-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1200\/JCO.2005.04.4669","article-title":"Improving long-term outcomes for patients with liver metastases from colorectal cancer","volume":"23","author":"Chong","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180110114404_b23-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","article-title":"An update on hepatic arterial infusion chemotherapy for colorectal cancer","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"key20180110114404_b24-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer","volume":"343","author":"Saltz","year":"2000","journal-title":"Irinotecan Study Group N Engl J Med"},{"key":"key20180110114404_b25-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.00.349","article-title":"Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma","volume":"23","author":"Leonard","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"key20180110114404_b26-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S0168-8278(02)00432-4","article-title":"Hepatocellular carcinoma: present status and future prospects","volume":"38","author":"Llovet","year":"2003","journal-title":"J Hepatol"},{"key":"key20180110114404_b27-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"key20180110114404_b28-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"key20180110114404_b29-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ctrv.2004.04.002","article-title":"Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview","volume":"30","author":"Barber","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"key20180110114404_b30-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02575467","article-title":"Hepatic artery infusion and chemoembolization in the management of liver metastases","volume":"13","author":"Wallace","year":"1990","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20180110114404_b31-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1148\/radiol.2501080295","article-title":"Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study","volume":"250","author":"Vogl","year":"2009","journal-title":"Radiology"},{"key":"key20180110114404_b32-ijo-41-04-1213","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7819-7-80","article-title":"Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report","volume":"7","author":"Martin","year":"2009","journal-title":"World J Surg Oncol"},{"key":"key20180110114404_b33-ijo-41-04-1213"},{"key":"key20180110114404_b34-ijo-41-04-1213","first-page":"4347","article-title":"Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients","volume":"54","author":"de Forni","year":"1994","journal-title":"Cancer Res"},{"key":"key20180110114404_b35-ijo-41-04-1213","first-page":"13","article-title":"Irinotecan: toward clinical end points in drug development","volume":"12","author":"Pazdur","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"key20180110114404_b36-ijo-41-04-1213","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.4523","article-title":"A randomized phase II trial of a drug eluting bead in the treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization","author":"Lencioni","year":"2009"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1572\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T22:51:59Z","timestamp":1642891919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,7,25]]},"published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.3892\/ijo.2012.1572"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1572","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}